• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Glaukos Corporation Common Stock (NY:GKOS)

    182.00 +1.43 (+0.79%)
    Streaming Delayed Price Updated: 10:50 AM EDT, Aug 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Glaukos Corporation Common Stock

    < Previous 1 2 3 4 5 Next >
    News headline image
    Glaukos Announces Participation in Wells Fargo Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Second Quarter 2026 Financial Results
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Completion of Patient Enrollment in 510(k) Pivotal Study for PRESERFLO™ MicroShunt
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces First Quarter 2026 Financial Results
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces the Release of its 2025 Sustainability Report
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Receives Permanent J-code for Epioxa™
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Commercial Availability of Epioxa™, a Transformative Innovation in Interventional Keratoconus Care
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Participation in J.P. Morgan Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Third Quarter 2025 Financial Results
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces FDA Approval of Epioxa™
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Participation in Wells Fargo Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Second Quarter 2025 Financial Results
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    News headline image
    Glaukos Announces First Quarter 2025 Financial Results
    From Glaukos Corporation
    Via Business Wire
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.